Last month's articles are still available to JDD subscribers in our Archive Library. Please take some time to review October's article highlight and a few more we have hand selected…
Read More
By Allison Sit The City of Philadelphia issues a formal apology for unethical medical experiments performed at the Holmesburg Prison from the 1950s to the 1970s. The University of Pennsylvania…
Read More
The Journal of Drugs in Dermatology is making headlines in Healio including, “Hair Texture Changes Linked to Five Classes of Medication.” The article is based on the September study, “Systemic…
Read More
By Allison Sit The founders of a Midwest-based dermatology group have made a donation to ensure future dermatologists receive training on business and healthcare advocacy. The gift will create The…
Read More
Healio published several articles about recent Journal of Drugs in Dermatology studies including “Broadalumab Bests Other Biologics in Onset of Action in Psoriasis.” The article is based on “Onset of…
Read More
By Allison Sit The FDA recently issued warning letters to three companies for selling unapproved new drugs for mole and skin tag removal, according to a news release. Amazon.com, Ariella…
Read More
Shape magazine was one of several publications that highlighted studies from the Journal of Drugs in Dermatology this month. The magazine’s article, “Does Using Castor Oil for Hair Growth Actually…
Read More
By Allison Sit Babies may have a lower risk of eczema if their mothers take vitamin D during pregnancy, according to a new study in the British Journal of Dermatology.…
Read More
The June issue of the Journal of Drugs in Dermatology made several headlines with Healio recently. One article, “Rosacea More Common Than Expected Among Patients With Skin of Color,” was…
Read More
By Allison Sit May marks the 20th anniversary of the Journal of Drugs in Dermatology. Launched in 2002 by dermatologist Perry Robins, MD, the JDD is now considered the fastest…
Read More
Healio published several articles recently about studies from the May issue of the Journal of Drugs in Dermatology. One article, “COVID-19 Precautions Linked with Delays in Skin Cancer Treatment,” was…
Read More
By Allison Sit The FDA has approved Olumiant (baricitinib) as a first-in-disease systemic treatment for adults with severe alopecia areata. Olumniant is a once-daily, oral JAK inhibitor. "People with alopecia…
Read More
